The Health Sciences Institute is intended to provide cutting-edge health information.
Nothing on this site should be interpreted as personal medical advice. Always consult with your doctor before changing anything related to your healthcare.

Painkiller intake may be associated with hypertension

Reality Double Check

My husband came running into the living room to see what was the matter. Apparently I had let out a yelp loud enough to give him the impression that the couch had burst into flames or something.

I was in distress all right. But there was no need for fire extinguishers or a 911 call.

I’d been watching ABC’s World News Tonight when anchor Charles Gibson began a segment that he characterized as “a reality check.” (Insert yelp here.)

Sorry, Charlie. Time for a double check on that “reality.”

Nurses in pain

ABC’s “reality check” concerned a study just published in the American Heart Association (AHA) journal Hypertension. We’ll take a quick look at the study and then get back to ABC in a moment.

A team from Brigham and Women’s Hospital (BWH) at Harvard University analyzed data from the first and second Nurses’ Health Studies. Using information from questionnaires, the researchers gathered data on hypertension and painkiller use in more than 5,000 women, ages 51-77 in the first study and ages 34-53 in the second study. None of the women had hypertension at the outset of either study.

Results showed that aspirin intake had no association with the development of hypertension. But other painkillers didn’t fare as well:

  • Women in the older age group who used an average of 400 mg of ibuprofen per day had an 80 percent increased risk of hypertension compared to women who didn’t use ibuprofen.
  • Women in the younger group who used 400 mg of ibuprofen per day had a 60 percent increased risk of hypertension
    Women in either group who took an average of 500 mg or more of acetaminophen daily were twice as likely to develop hypertension compared to women who didn’t use the drug

In the published study, the authors write: “Because acetaminophen and nonsteroidal anti-inflammatory drugs are commonly used, they may contribute to the high prevalence of hypertension in the United States.”

Follow the money

In many e-Alerts I’ve taken studies to task when their designs were obviously flawed or the conclusions clearly biased. And basically that’s all ABC did with the BWH study. Or that’s how it appears on the surface.

What made me yelp was this: I’ve never seen ABC take apart a study and criticize the design. In just the past month we’ve seen vitamin E and echinacea treated unfairly by flawed research that was widely reported.

But in both those cases ABC just got in line with the rest of the mainstream press and reported only the negative results, not the glaring flaws.

So why did ABC pick this study for a grilling? Well, there could be all sorts of reasons. But, hmmm, let’s see, the possibility that comes to mind most readily is the fact that the network receives millions of dollars in advertising revenues from the makers of acetaminophen and ibuprofen products.

Just a thought.

Realitychecked

Here’s how the ABC piece went. Reporter John McKenzie stated that, “Many doctors today were unusually critical of this latest research, and they worried about the fear it could trigger.” Well heaven FORBID there should be any fear of these painkillers which have been PROVEN to cause gastrointestinal problems along with kidney and liver damage when taken in excess. But fears about vitamin E, which is safe and has been shown
to promote heart health? Hey, no problem there.

But who were these “many doctors”? And in what context were they voicing their concerns? Did the doctors call a press conference? Or did an industry advocacy group issue a statement? Did the doctors contact ABC? Or did ABC contact the doctors? Mr. McKenzie doesn’t say. He just refers
to “many doctors.” And then quotes two.

Here are the flaws in the BWH study, according to the doctor du:

  • Researchers didn’t measure the subjects’ blood pressure, they relied on subjects to report on any diagnosis of hypertension
  • Researchers didn’t count the pills subjects were taking – again they relied on the subjects to report painkiller intake
  • There was no follow up to see if the amount or type of painkillers taken at the beginning of the study changed by the end of the study
  • The study didn’t rule out other potential causes of hypertension

These are valid points, although a couple of them are fairly weak. For instance, if a nurse says she’s been diagnosed with high blood pressure, well c’mon, she’s a NURSE! She would know.

What Mr. McKenzie doesn’t note is that the researchers are well aware that their findings are not the last word on the question of a
painkiller/hypertension link.

In an AHA press release about the study, lead author, John Phillip Forman, M.D., states that more research is needed to confirm the
findings, and adds, “It is important to emphasize that our study is not proof that these drugs will raise blood pressure in all women. Rather, women and their doctors should use caution when using these drugs.”

That seems like a reasonable conclusion: Be cautious. Talk to your doctor.

The ABC report, on the other hand, ends on this note: “The doctors told ABC News there’s no reason for people to change how they’re using these pain pills, at least not based on this study.”

So if you’re a middle-aged woman who’s taking acetaminophen or ibuprofen daily, should you ignore this study and make no change in your painkiller use? Or should you be cautious and talk to your doctor?

One of those suggestions is clearly flawed.

Sources:
“Non-Narcotic Analgesic Dose and Risk of Incident Hypertension in US Women” Hypertension, Published online before print, 8/15/05, hyper.ahajournals.org
“Doctors Question Hypertension-Painkillers Link” John McKenzie, ABC News, 8/16/05, abcnews.go.com
“Most Popular Painkillers Linked to High Blood Pressure in Women” American Heart Association press release, 8/17/05, medicalnewstoday.com

Get a free copy of 5 Household Items that Cause Cancer

By texting HSI to 844-539-1128, you are providing your electronic signature expressly consenting to be called and texted (including by prerecorded messages, using an autodialer, and/or automated means) with alerts, stories, reports, and marketing communications from Institute of Health Sciences, LLC. and its authorized representatives at the phone number you provide, including landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also consent and unconditionally agree to our Privacy Policy and Terms of Use, including the arbitration provision and class action waiver contained therein. Msg&data rates may apply. 15 Msgs/Month. You are not required to agree to this as a condition of making a purchase.

Terms & Conditions

The following Terms and Conditions apply to your use of the website located at hsionline.com (the “website”) and any text messages that you send to or receive from the Institute of Health Sciences, L.L.C. These Terms and Conditions constitute a binding agreement (“Agreement”) between you (“you”) Institute of Health Sciences, L.L.C (“we”, “us”, etc.)  Please read these terms carefully. 

By providing your telephone number to us, texting us a short code listed on the website, or otherwise indicate your agreement to these Terms and Conditions, you are agreeing to the mandatory arbitration provision and class action waiver below. 

ARBITRATION IS MANDATORY AND THE EXCLUSIVE REMEDY FOR ANY AND ALL DISPUTES RELATED TO THIS WEBSITE, THIS AGREEMENT, AND ANY TELEPHONE CALLS, EMAILS, OR TEXT MESSAGES THAT YOU RECEIVE FROM OR ON BEHALF OF US, UNLESS SPECIFIED BELOW OR UNLESS YOU OPT-OUT.

Text Messaging and Telemarketing Terms and Conditions

When you provide your telephone number on this website or send a text message to us with or from a short-code, you agree to receive alerts and communications, and marketing messages including those sent via automated telephone dialing system, text messages, SMS, MMS, and picture messages from Institute of Health Sciences, L.L.C at the phone number you provide on this website or the phone number from which you text the short code, including on landlines and wireless numbers, even if the phone number is on a corporate, state or national Do Not Call list. You also agree to the mandatory arbitration provision and class action waiver below. Your consent is not required to purchase goods or services. Message & data rates may apply.

You may opt-out at any time by texting the word STOP to the telephone number from which you receive the text messages.  Call 1-888-213-0764 to learn more.  By providing your telephone number, you agree to notify us of any changes to your telephone number and update your account us to reflect this change. Your carrier may charge you for text messages and telephone calls that you receive, or may prohibit or restrict certain mobile features, and certain mobile features may be incompatible with your carrier or mobile device. Contact your carrier with questions regarding these issues.

Dispute Resolution by Binding Arbitration and Class Action Waiver

Any dispute relating in any way to telephone calls, emails, or text messages that you receive from or on behalf of Institute of Health Sciences, L.L.C this website, or this Agreement (collectively “Disputes”) shall be submitted to confidential arbitration and shall be governed exclusively by the laws of the State of Maryland, excluding its conflict of law provisions.  For the avoidance of doubt, all claims arising under the Telephone Consumer Protection Act and state telemarketing laws shall be considered “Disputes” that are subject to resolution by binding individual, confidential arbitration.

If a Dispute arises under this Agreement, you agree to first contact us at 1-888-213-0764 or help@hsionline.com. Before formally submitting a Dispute to arbitration, you and we may choose to informally resolve the Dispute.  If any Dispute cannot be resolved informally, you agree that any and all Disputes, including the validity of this arbitration clause and class action waiver, shall be submitted to final and binding arbitration before a single arbitrator of the American Arbitration Association (“AAA”) in a location convenient to you or telephonically. Either you or we may commence the arbitration process by submitting a written demand for arbitration with the AAA, and providing a copy to the other party.  The arbitration will be conducted in accordance with the provisions of the AAA’s Commercial Dispute Resolutions Procedures, Supplementary Procedures for Consumer-Related Disputes, in effect at the time of submission of the demand for arbitration.  Except as may be required by law as determined by the arbitrator, no party or arbitrator may disclose the existence, content or results of any arbitration hereunder without the prior written consent of both parties. Institute of Health Sciences, L.L.C will pay all of the filing costs.  Without limiting the foregoing, YOU EXPRESSLY AGREE TO SUBMIT TO ARBITRATION ALL DISPUTES RELATING TO ANY TEXT MESSAGES OR TELEPHONE CALLS YOU RECEIVE FROM OR ON BEHALF OF US OR ANY ENTITY WITH WHOM WE MAY SHARE YOUR TELEPHONE NUMBER.  Further, we both agree that all entities with whom we share your telephone numbers shall be third party beneficiaries of this Agreement to Arbitrate Disputes, and that those entities have the same rights as Institute of Health Sciences, L.L.C to enforce this arbitration provision.

Notwithstanding the foregoing, the following shall not be subject to arbitration and may be adjudicated only in the state and federal courts of Maryland: (i) any dispute, controversy, or claim relating to or contesting the validity of our or one of our family company’s intellectual property rights and proprietary rights, including without limitation, patents, trademarks, service marks, copyrights, or trade secrets; (ii) an action by us for temporary or preliminary injunctive relief, whether prohibitive or mandatory, or other provisional relief; (iii) any legal action by us against a non-consumer; or (iv) interactions with governmental and regulatory authorities.  You expressly agree to refrain from bringing or joining any claims in any representative or class-wide capacity, including but not limited to bringing or joining any claims in any class action or any class-wide arbitration.

The arbitrator’s award shall be binding and may be entered as a judgment in any court of competent jurisdiction. To the fullest extent permitted by applicable law, no arbitration under this Agreement may be joined to an arbitration involving any other party subject to this Agreement, whether through a class action, private attorney general proceeding, class arbitration proceedings or otherwise.

YOU UNDERSTAND THAT YOU WOULD HAVE HAD A RIGHT TO LITIGATE IN A COURT, TO HAVE A JUDGE OR JURY DECIDE YOUR CASE AND TO BE PARTY TO A CLASS OR REPRESENTATIVE ACTION.  HOWEVER, YOU UNDERSTAND AND AGREE TO HAVE ANY CLAIMS DECIDED INDIVIDUALLY AND ONLY THROUGH ARBITRATION.  You shall have thirty (30) days from the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, to opt out of this arbitration agreement, by contacting us by email at help@hsionline.com or by mail Health Sciences Institute, PO Box 913, Frederick, MD 21705-0913. If you do not opt out by the earliest of the date that you visit the website, the date you submit information to us through the website, or the date that you send a text message to us, then you are not eligible to opt out of this arbitration agreement.

Electronic Signatures

All information communicated on the website is considered an electronic communication.  When you communicate with us through or on the website, by text message or telephone, or via other forms of electronic media, such as e-mail, you are communicating with us electronically.  You agree that we may communicate electronically with you and that such communications, as well as notices, disclosures, agreements, and other communications that we provide to you electronically, are equivalent to communications in writing and shall have the same force and effect as if they were in writing and signed by the party sending the communication.

You further acknowledge and agree that by clicking on a button labeled “ORDER NOW”, “SUBMIT”, “I ACCEPT”, “I AGREE”, “YES”, by texting a short code to us in response to a request on this website, or by clicking or similar links or buttons, you are submitting a legally binding electronic signature and are entering into a legally binding contract.  You acknowledge that your electronic submissions constitute your agreement and intent to be bound by this Agreement.  Pursuant to any applicable statutes, regulations, rules, ordinances or other laws, including without limitation the United States Electronic Signatures in Global and National Commerce Act, P.L. 106-229 (the “E-Sign Act”) or other similar statutes, YOU HEREBY AGREE TO THE USE OF ELECTRONIC SIGNATURES, CONTRACTS, ORDERS AND OTHER RECORDS AND TO ELECTRONIC DELIVERY OF NOTICES, POLICIES AND RECORDS OF TRANSACTIONS INITIATED OR COMPLETED THROUGH THE WEBSITE.  Furthermore, you hereby waive any rights or requirements under any statutes, regulations, rules, ordinances or other laws in any jurisdiction which require an original signature, delivery or retention of non-electronic records, or to payments or the granting of credits by other than electronic means You may receive a physical paper copy of this contract by contacting us at help@hsionline.com.

Privacy Policy

Please read our Privacy Policy, which is incorporated herein by reference.  In the event of any conflict between these Terms and Conditions and the Privacy Policy, these Terms shall control.

Contact Us

You may contact us by telephone at 1-888-213-0764 or by email at help@hsionline.com.